Chair & CEO at Eli Lilly and Company
Biology is now a data problem. With NVIDIA we are building a system that can simulate and rank billions of potential interactions across protein structures, genomics, clinical histories, and imaging. The goal is not for the machine to invent drugs, but to narrow the search so scientists start from higher-probability ideas.
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Use this answer in your research, article, or academic work
